Recombinant Human IFN-Α6 Mammalian Cell-Expressed Human Interferon Alpha 6 (Alpha K) with HSA Cat

Recombinant Human IFN-Α6 Mammalian Cell-Expressed Human Interferon Alpha 6 (Alpha K) with HSA Cat

Recombinant human IFN-α6 Mammalian cell-expressed human interferon alpha 6 (alpha K) with HSA Cat. code: rcyc-hifna6 https://www.invivogen.com/human-ifna6 For research use only, not for diagnostic or therapeutic use Version 18I12-NJ PRODUCT INFORMATION BACKGROUND Contents Type I interferons (IFN) include the IFN-α family, IFN-β, IFN-ε, IFN-κ • 1 µg of lyophilized recombinant human IFN-α6 and IFN-ω. IFN-αs are important anti-viral cytokines that also play Note: This product is sterile filtered prior to lyophilization. anti-proliferative and immuno-modulatory functions. The human IFN-α • 1.5 ml endotoxin-free water family comprises 13 genes encoding 12 proteins, IFN-α13 being identical to IFN-α1. All IFN-αs bind to a common heterodimer receptor IFNAR1/ Storage and stability IFNAR2. The ternary complex signals through the Janus kinase (JAK) • Recombinant human IFN-α6 is shipped at room temperature. Upon and signal transducer and activator of transcription (STAT) signaling receipt it should be immediately stored at -20 °C. Lyophilized product is stable for 6 months at -20°C. pathway, inducing the formation of the ISGF3 transcriptional complex • Upon resuspension, prepare aliquots of recombinant human IFN-α6 and (STAT1/STAT2/IRF9). ISGF3 binds to IFN-stimulated response elements 2 store at -80 °C for 4 months. (ISRE) in the promoters of numerous IFN-stimulated genes (ISGs) . Note: Avoid repeated freeze-thaw cycles. Quality control IFN-α IFN-α • Purity: ≥ 95% (SDS-PAGE) Low affinity High affinity • Endotoxin: ≤ 1 EU/µg • The biological activity has been confirmed using HEK-Blue™ IFN-α/β IFNAR1 IFNAR2 cells (see validation data sheet available on our website). TyK2 JAK1 Other factors • The units have been determined for each lot using hIFN-α2 laboratory e.g. STAT2/STAT6, standard calibrated to the WHO International Standard Interferon Alpha Crkl/STAT5 (Human leukocyte-derived) from the National Institute for Biological 1 STAT2 Standards and Control (NIBSC; code 94/784) . 1 2 ISGF3 TAT TAT 1. http://www.nibsc.org/documents/ifu/94-784.pdf. National Institute for Biological complex } S S STAT6 Standards and Control. Potters Bar, Hertfordshire, EN6 3QG. WHO International IRF9 Crkl Laboratory for Biological Standards. UK Official Medicines Control Laboratory. STAT5 Tunable ISGs CHARACTERISTICS Robust ISGs (anǎ-proliferaǎve, ISRE (anǎ-viral) GAS Source: Mammalian; Chinese hamster ovary (CHO) cells ISRE immuno-modulatory) Molecular mass: ≈ 22 kDa (SDS-PAGE) Robust and tunable ISGs induction by IFN-αs. Chromosome: 9 UniProt ID: P05013 Human IFN-α genes have evolved under strong selective pressure, Alternate name: IFN-alpha K suggesting a non-redundant role between IFN-α subtypes3. Although Formulation: Recombinant human IFN-α6 was lyophilized from a most studies have focused on IFN-α2 and IFN-α8, a consensus model for 0.2 µm filtered phosphate buffer solution (pH 7.4) containing 2% human all IFN-αs has emerged depending on the affinity of a particular IFN-α serum albumin (HSA) and 5% saccharose. subtype for IFNAR. Low affinity IFN-α subtypes signal strictly through Solubility: 100 µg/ml in water ISGF3 and induce robust ISGs, such as PKR, ISG56, and IFI16, which display anti-viral functions. Conversely, high affinity IFN-α subtypes signal through ISGF3 and other factors, which activate “tunable” ISGs” such as CXCL10, IL-8, and ISG15, that induce anti-proliferative and APPLICATIONS 4 • Cellular assays (e.g. using HEK-Blue™ IFN-α/β cells) immuno-modulatory functions . IFN-α8, IFN-α10 and IFN-α14 have • ELISA. been identified as the most potent inducers of ISGs, while IFN-α1 is the weakest5. TECHNICAL SUPPORT InvivoGen USA (Toll‑Free): 888‑457‑5873 InvivoGen USA (International): +1 (858) 457‑5873 InvivoGen Europe: +33 (0) 5‑62‑71‑69‑39 www.invivogen.com InvivoGen Hong Kong: +852 3622‑3480 E‑mail: [email protected] PRODUCT DESCRIPTION Natural human IFN-α6 is induced in peripheral blood mononuclear cells upon incubation with CpG-oligonucleotides and in plasmacytoid dendritic cells upon incubation with CpG-oligonucleotides or imiquimod6. Human IFN-α6 is classified as an intermediate/strong ISG inducer5,7 with strong anti-viral activity against human metapneumovirus, mumps virus (MuV), and human immunodeficiency virus (HIV)8. Human IFN-α6 expression is IFN-α receptor-dependent as it is induced by other IFN-α subtypes upon infection with low doses of Sendai virus in vitro9. 2. Schreiber G. 2017. The molecular basis for differential type I interferon signaling. J. Biol. Chem. 292:7285-94. 3. Manry J. et al., 2011. Evolutionary genetic dissection of human interferons. J. Exp. Med. 208:2747-59. 4. Levin D. et al., 2014. Multifaceted activities of type I interferon are revealed by a receptor antagonist. Sci. Signal. 7(327). ra50. 5. Kurunganti S. et al., 2014. Production and characterization of thirteen human type-I interferon-α subtypes. Protein Expr. Purif. 103: 75-83. 6. Hillyer P. et al., 2012. Expression profiles of human interferon-alpha and interferon- lambda subtypes are ligand- and cell-dependent. Immunol. Cell. Biol. 90(8):774-83. 7. Moll H.P. et al., 2011. The differential activity of interferon-α subtypes is consistent among distinct target genes and cell types. Cytokines. 53:52-59. 8. George J. & Mattapallil J.J., 2018. Interferon-α subtypes as an adjunct therapeutic approach for human immunodeficiency virus functional cure. Front. Immunol. 9:999. 9. Zaritsky L.A. et al., 2015. Virus multiplicity of infection affects type I interferon subtype induction profiles and interferon-stimulated genes. J. Virol. 89:11534-48. PROCEDURE Preparation of stock solution (20 μg/ml): 1. Add 50 µl endotoxin-free water (provided) to 1 µg of recombinant hIFN-α. 2. Mix by pipetting. Do not vortex. 3. Use immediately or prepare aliquots of recombinant human IFN-α and store at -80 °C for 4 months. Avoid freeze-thaw cycles. 4. Further dilutions can be prepared in the appropriate aqueous buffer, such as cell culture medium containing serum. RELATED PRODUCTS Product Description Cat. Code Recombinant hIFN-α set Set of 12 hIFN-α subtypes rcyck-hifna Anti-hIFN-α-IgG Neutralizing antibody mabg-hifna-3 HEK-Blue™ IFN-α/β cells Type I IFN reporter cells hkb-ifnab LumiKine™ Xpress hIFN-α Bioluminescent ELISA kit luex-hifna TECHNICAL SUPPORT InvivoGen USA (Toll‑Free): 888‑457‑5873 InvivoGen USA (International): +1 (858) 457‑5873 InvivoGen Europe: +33 (0) 5‑62‑71‑69‑39 www.invivogen.com InvivoGen Hong Kong: +852 3622‑3480 E‑mail: [email protected].

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us